Tag: Europe

Amid COVID-19 booster data dilemma, EU nations' plans diverge

LONDON (Reuters) – A patchwork of campaigns for an extra COVID-19 shot are being rolled out across the European Union even before the region’s drug watchdog rules on whether they are safe and effective.FILE PHOTO: A health worker prepares a booster dose of a coronavirus disease (COVID-19) vaccine, as vaccinations jump in Italy after the

CureVac’s COVID-19 Vaccine Attracts Rising Interest

FRANKFURT (Reuters) – German biotech firm CureVac said it has seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, as concerns over rare side effects have hit some other coronavirus shots. A CureVac spokesman said on Thursday that requests have been coming in from various quarters, including governments

Australia Reports Second AstraZeneca Blood Clot Case

SYDNEY (Reuters) – Australia said on Tuesday a second person had been diagnosed with a blood clot after receiving the AstraZeneca Plc vaccine but there had been no rise in inoculation cancellations as authorities try to steady a bungled immunisation campaign. This week Australia abandoned a goal of vaccinating all of its nearly 26 million

UK reports highest number of new COVID cases since April 1

FILE PHOTO: Nurses react as they treat a COVID-19 patient in the ICU (Intensive Care Unit) at Milton Keynes University Hospital, amid the spread of the coronavirus disease (COVID-19) pandemic, Milton Keynes, Britain, January 20, 2021. REUTERS/Toby MelvilleLONDON (Reuters) – Britain reported the highest number of new COVID cases since April 1 on Monday, with

Roche's Evrysdi wins EU approval for spinal muscular atrophy

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) – Roche’s Evrysdi has won approval from the European Commission as the first and only at-home treatment for spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday. It has

Roche, Novartis approvals in Europe signal more head-to-head competition

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) -Swiss drugmakers Roche and Novartis each won European approval for drugs on Tuesday in a sign that the rival Basel-based companies are increasingly competing for the same patients. Roche’s Evrysdi,

UK's daily COVID-19 death toll falls to 17, a six-month low

FILE PHOTO: Medical workers move a patient between ambulances outside of the Royal London Hospital amid the spread of the coronavirus disease (COVID-19) pandemic, London, Britain, January 27, 2021. REUTERS/Toby MelvilleLONDON (Reuters) -The United Kingdom’s daily death toll from COVID-19 fell to 17 on Monday, the lowest figure in about six months, official data showed.

Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds

FILE PHOTO: Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company’s headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd WiegmannZURICH (Reuters) – Idorsia’s insomnia drug was accepted for review by U.S. regulators, the Swiss drugmaker said on Wednesday, as founder Jean-Paul

UK finds missing case of Brazil variant, says no sign it has spread

FILE PHOTO: A person works at a minibus that was converted into a COVID-19 mobile test centre for people who can’t get to regular test centres, amid the spread of the coronavirus disease (COVID-19), in Walsall, Britain, February 8, 2021. REUTERS/Carl RecineLONDON (Reuters) – English health authorities have tracked down a previously-unidentified person who tested

Covid cases rising again in Europe: WHO

The number of new coronavirus cases has risen in Europe after six weeks of decline, the World Health Organization said on Thursday. “Last week, new cases of COVID-19 in Europe rose nine percent to just above one million. This brought a promising six-week decline in new cases to an end, with more than half of

EU Considers Switch to COVID-19 Vaccine Emergency Approvals

BRUSSELS (Reuters) – The European Commission said on Tuesday that it was considering emergency approvals for COVID-19 vaccines as a faster alternative to more rigorous conditional marketing authorisations which have been used so far. The move would mark a big shift in approach to vaccine approvals, as it would entail using a procedure that the

EU Mulls Vaccination Passports to Resurrect Tourism After COVID-19

BRUSSELS (Reuters) – European Union leaders will agree on Thursday to work on certificates of vaccination for EU citizens who have had an anti-COVID shot, with southern EU countries that depend heavily on tourism desperate to rescue this summer’s holiday season. Lockdowns to slow the pandemic caused the deepest ever economic recession in the 27-nation

Holloway keen to push his limits after record-breaking run

(Reuters) – American Grant Holloway said he was not surprised by his blistering pace on the World Indoor Tour circuit this year as he eclipsed the long-standing world indoor 60m hurdles record in Madrid.Slideshow ( 2 images )Holloway, the outdoor 110m hurdles world champion, won his 10th race of the year on Wednesday as he